Cargando…

Water exchange rate across the blood‐brain barrier is associated with CSF amyloid‐β 42 in healthy older adults

INTRODUCTION: We tested if water exchange across the blood‐brain barrier (BBB), estimated with a noninvasive magnetic resonance imaging (MRI) technique, is associated with cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) and neuropsychological function. METHODS: Forty cognitivel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gold, Brian T., Shao, Xingfeng, Sudduth, Tiffany L., Jicha, Gregory A., Wilcock, Donna M., Seago, Elayna R., Wang, Danny J.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717840/ https://www.ncbi.nlm.nih.gov/pubmed/33949773 http://dx.doi.org/10.1002/alz.12357

Ejemplares similares

Plasma TDP‐43 levels are associated with neuroimaging measures of brain structure in limbic regions
por: Bauer, Christopher E., et al.
Publicado: (2023)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

White Matter Hyperintensity Volume and Location: Associations With WM Microstructure, Brain Iron, and Cerebral Perfusion
por: Bauer, Christopher E., et al.
Publicado: (2021)

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014)

Lithium Treatment of APPSwDI/NOS2−/− Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
por: Sudduth, Tiffany L., et al.
Publicado: (2012)

Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events
por: Weekman, Erica M., et al.
Publicado: (2019)

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
por: Mattsson, N, et al.
Publicado: (2013)

Decreased water exchange rate across blood–brain barrier in hereditary cerebral small vessel disease
por: Li, Yingying, et al.
Publicado: (2023)

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
por: Hu, William T, et al.
Publicado: (2015)

White matter hyperintensities influence distal cortical β‐amyloid accumulation in default mode network pathways
por: Ali, Doaa G., et al.
Publicado: (2023)

Hierarchical Clustering Analyses of Plasma Proteins in Subjects With Cardiovascular Risk Factors Identify Informative Subsets Based on Differential Levels of Angiogenic and Inflammatory Biomarkers
por: Winder, Zachary, et al.
Publicado: (2020)

Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function
por: Ali, Doaa G., et al.
Publicado: (2023)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
por: Campbell, Michelle R., et al.
Publicado: (2021)

Automation vs. Experience: Measuring Alzheimer’s Beta-Amyloid 1–42 Peptide in the CSF
por: Kollhoff, Alexander L., et al.
Publicado: (2018)

Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice
por: Weekman, Erica M, et al.
Publicado: (2014)

Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain
por: Weekman, Erica M., et al.
Publicado: (2017)

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
por: Oh, Esther S., et al.
Publicado: (2018)

Cortical iron disrupts functional connectivity networks supporting working memory performance in older adults
por: Zachariou, Valentinos, et al.
Publicado: (2020)

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
por: Wisch, Julie K., et al.
Publicado: (2023)

Correction: Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
Publicado: (2018)

Lower CSF Amyloid-Beta(1–42) Predicts a Higher Mortality Rate in Frontotemporal Dementia
por: Vieira, Daniela, et al.
Publicado: (2019)

Comparison Between Blood-Brain Barrier Water Exchange Rate and Permeability to Gadolinium-Based Contrast Agent in an Elderly Cohort
por: Shao, Xingfeng, et al.
Publicado: (2020)

An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele
por: Meuret, Cristiana J., et al.
Publicado: (2023)

Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent
por: Pascale, Crissey L, et al.
Publicado: (2011)

Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice
por: Latta, Clare H, et al.
Publicado: (2015)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
por: Hansson, Oskar, et al.
Publicado: (2019)

Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia
por: Braun, David J., et al.
Publicado: (2019)

Enlarged Perivascular Spaces Are Negatively Associated With Montreal Cognitive Assessment Scores in Older Adults
por: Libecap, Timothy J., et al.
Publicado: (2022)

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
por: Colletti, Tiziana, et al.
Publicado: (2021)

k-space weighted image average (KWIA) for ASL-based dynamic MR angiography and perfusion imaging
por: Zhao, Chenyang, et al.
Publicado: (2021)

Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
por: Liu, Chen-Yang, et al.
Publicado: (2018)

PICALM rs3851179 Variants Modulate Left Postcentral Cortex Thickness, CSF Amyloid β42, and Phosphorylated Tau in the Elderly
por: Wu, Zhiwei, et al.
Publicado: (2022)

Age-dependent inverse correlations in CSF and plasma amyloid-β(1–42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice
por: Cho, Soo Min, et al.
Publicado: (2016)

Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue
por: Weekman, Erica M., et al.
Publicado: (2022)

An automated clinical mass spectrometric method for identification and quantification of variant and wild‐type amyloid‐β 1‐40 and 1‐42 peptides in CSF
por: DeMarco, Mari L., et al.
Publicado: (2020)

Quenched hydrogen-deuterium exchange NMR of a disease-relevant Aβ(1-42) amyloid polymorph
por: Wälti, Marielle Aulikki, et al.
Publicado: (2017)

Nanoparticulate flurbiprofen reduces amyloid-β(42) generation in an in vitro blood–brain barrier model
por: Meister, Sabrina, et al.
Publicado: (2013)

Cellular Specificity of the Blood–CSF Barrier for Albumin Transfer across the Choroid Plexus Epithelium
por: Liddelow, Shane A., et al.
Publicado: (2014)

Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure
por: Behl, Mamta, et al.
Publicado: (2009)

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β ((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop
por: Teunissen, Charlotte E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jgmi036aia00tlrmio2i0mgbgn